Abstract:Background/objective: Auditory neuropathy/dys-synchrony, characterized by absent auditory brainstem responses, normal otoacoustic emissions or cochlear microphonics, and word discrimination disproportional to the pure-tone audiogram, may be accompanied by perceptual consequences that could jeopardize language acquisition in affected children. However, the related evidence is constantly changing leading to a serious debate. The aim of the present paper is to review the current knowledge on auditory neuropathy/dys-synchrony, and to present the therapeutic strategies that can be employed in its management, taking into account the potentially underlying pathophysiology. Materials/methods: Literature review from Medline and database sources. Related books were also included. Study selection: Controlled clinical trials, prospective and retrospective cohort studies, nested-based case-control and analytical family studies, laboratory and electrophysiological studies, animal models, case-reports, joint statements and review articles. Data synthesis: Auditory neuropathy/dys-synchrony, in contrast to what is widely believed, is a very frequent disease, responsible for approximately 8% of newly diagnosed cases of hearing loss in children per year. Hyperbilirubinemia and hypoxia represent major risk factors, whereas generalized neuropathic disorders, or a genetic substrate involving the otoferlin gene, are responsible for the phenotype of auditory neuropathy/dys-synchrony in certain cases. Auditory nerve myelinopathy and/or desynchrony of neural discharges are the most probable underlying pathophysiologic mechanisms. Genetic testing may be helpful in cases of non-syndromic prelingual children. Auditory neuropathy/dys-synchrony management aims at restoring the compromised processing of auditory information, either through conventional amplification and/or alternative forms of communication, or by cochlear implantation (combined with intensive speech and language therapy). Conclusion: Auditory neuropathy/dys-synchrony is more frequent than considered in the past, especially amongst hearing-impaired children. Accurate diagnosis, based on subjective and objective hearing assessment techniques (including the various electrophysiological assessment measures), and timely treatment of the affected children is of paramount importance, with hearing aids, intensive speech and language therapy (and sign language when indicated) providing the mainstay of habilitation, and cochlear implantation representing a valid therapeutic alternative.

Nervous System Hereditary Disease Patients Combined with Auditory Neuropathy: a Literature Review of 4 Cases

Audiological and Genetic Studies on Large Families with Non-Syndromic Deafness

The coexistence of mitochondrial ND6 T14484C and 12S rRNA A1555G mutations in a Chinese family with Leber's hereditary optic neuropathy and hearing loss.

Clinical Analysis of a Charcot-Marie-Tooth Disease Type 2F Family in China

The genetic analysis of patients with non-syndrome deafness come from twenty-two families in Yuyao, Zhe-jiang province

Clinical and Molecular Analysis of a Four-Generation Chinese Family with Aminoglycoside-Induced and Nonsyndromic Hearing Loss Associated with the Mitochondrial 12S Rrna C1494T Mutation

[A New Mutation in the Connexin 32 Gene of a Chinese Family with Charcot-Marie-Tooth Disease Associated with Central Conduction Slowing].

Clinical and Molecular Characterization of a Chinese Patient with Auditory Neuropathy Associated with Mitochondrial 12S Rrna T1095C Mutation.

Case report: Clinical and genetic analysis of a family with nonsyndromic auditory neuropathy

Clinical and genetic architecture of a large cohort with auditory neuropathy

Clinical characteristics of patients with unilateral auditory neuropathy

Retro-labyrinthine Lesion Site Detected by Galvanic Vestibular Stimulation Elicited Vestibular-evoked Myogenic Potentials in Patients with Auditory Neuropathy

Auditory Neuropathy as the Initial Phenotype for Patients With ATP1A3 c.2452 G > A: Genotype-Phenotype Study and CI Management

Auditory Neuropathy Spectrum Disorders: From Diagnosis to Treatment: Literature Review and Case Reports

Genetic etiological analysis of auditory neuropathy spectrum disorder by next-generation sequencing

Audiological Evaluation in Chinese Patients with Mitochondrial Encephalomyopathies

Relationship Between Patients with Clinical Auditory Neuropathy Spectrum Disorder and Mutations in Gjb2 Gene

Auditory Neuropathy/Auditory Synaptopathy

Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder

Objective Determination of Site-of-Lesion in Auditory Neuropathy

Auditory neuropathy: endocochlear lesion or temporal processing impairment? Implications for diagnosis and management